← Back to the page you were readingYou opened this term from another page.

Supplemental examination

Also called patent supplemental examination, supplemental patent examination

Published by Patsnap Team Updated 7 sources
Definition

Supplemental examination is a US procedure allowing a patent owner to ask the USPTO to consider, reconsider or correct information believed relevant to the patent under 35 U.S.C. 2571.

The Office concludes the examination with a certificate indicating whether the submitted information raises a substantial new question of patentability, and must order reexamination if the certificate identifies such a question1.

Used byThe owner or owners of the entire right, title and interest in the patent2
Comes upDuring the patent's period of enforceability2
Governed by35 U.S.C. 257 and 37 CFR 1.601 to 1.6251,2,3
Not to confuse withThe resulting ex parte Reexamination, ordered if a substantial new question is identified1,3
01

Who requests it and what can be submitted

Section 1.601 requires the request to be filed by the owner or owners of the entire right, title and interest in the patent, permits filing during the period of enforceability, and prohibits third parties from filing papers or otherwise participating in supplemental examination2.

MPEP 2801 explains that submitted information is not limited to patents and printed publications and may involve any ground of patentability4.

Section 1.605 permits no more than twelve items of information per request and permits multiple requests during the period of enforceability, with written transcripts required for audio or video information5.

02

The determination and resulting reexamination

Under section 257(a), within three months after receipt of a request meeting the statutory requirements, the Director must conduct and conclude supplemental examination by issuing a certificate stating whether the information raises a substantial new question of patentability1.

Section 1.625(b) requires ex parte reexamination under section 257 when the certificate identifies a substantial new question raised by one or more submitted items3.

Section 257(b) requires that resulting reexamination address each substantial new question identified during supplemental examination and follows chapter 30 procedures except that the owner has no right to file the section 304 statement, notwithstanding chapter 30's patents-and-printed-publications limitations or any other provision of that chapter1.

MPEP 2823 explains that reexamination resulting from supplemental examination differs from ordinary Reexamination under section 302, including consideration of information beyond patents and printed publications and the absence of an owner statement under section 1.5306.

Section 1.620 prohibits interviews and amendments during supplemental examination itself7.

PointSupplemental examinationResulting ex parte reexamination under section 257
How it beginsRequested by the owner or owners of the entire right, title and interest2Ordered when the supplemental-examination certificate identifies a substantial new question of patentability1,3
CertificateStates whether the submitted information raises a substantial new question of patentability1An ex parte reexamination certificate is published after the resulting proceeding concludes3
03

The limited statutory effect on unenforceability

Subject to section 257(c)(2), section 257(c)(1) bars holding a patent unenforceable on the basis of conduct relating to information not considered, inadequately considered or incorrect in a prior patent examination if that information was considered, reconsidered or corrected during supplemental examination1.

Section 257(c)(1) also provides that making a supplemental-examination request, or not making one, is not relevant to enforceability under section 2821.

Under section 257(e), if the Director becomes aware during supplemental examination or resulting reexamination that material fraud on the Office may have been committed in connection with the patent, the matter must also be referred to the Attorney General, in addition to other authorized action1.

Section 257(f) preserves criminal and antitrust sanctions, the Director's authority to investigate possible misconduct and impose sanctions in Office matters or proceedings, and the authority to issue chapter 3 regulations on misconduct sanctions for representatives1.

04

The two exceptions in section 257(c)(2)

  • Prior allegations, section 257(c)(2)(A): The protection in paragraph (c)(1) does not apply to an allegation pleaded with particularity in a civil action, or set forth with particularity in a notice received by the owner under section 505(j)(2)(B)(iv)(II) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 355(j)(2)(B)(iv)(II), before the date of the supplemental-examination request to consider, reconsider or correct the information forming the allegation's basis1.
  • Patent enforcement actions, section 257(c)(2)(B): In an action under section 337(a) of the Tariff Act of 1930, 19 U.S.C. 1337(a), or 35 U.S.C. 281, the protection in paragraph (c)(1) does not apply to any defense raised in the action based on information considered, reconsidered or corrected pursuant to a supplemental-examination request, unless supplemental examination and any reexamination ordered pursuant to that request both concluded before the action was brought1.
05

Questions people ask

Patsnap EurekaEureka IP

Search before filing

Novelty Search AI Agent

An AI agent that searches prior art for your invention and compares each reference with it feature by feature.

Run Novelty Search
Can a third party request supplemental examination?

No, section 1.601 reserves filing to the owner or owners of the entire right, title and interest and bars third-party participation2.

Does supplemental examination always lead to reexamination?

No, ex parte reexamination is ordered under section 257 if the certificate identifies a substantial new question of patentability raised by one or more submitted items1,3.

Does filing a request alone remove an unenforceability defense?

No, section 257(c)(1) concerns information actually considered, reconsidered or corrected during supplemental examination, and section 257(c)(2) preserves the specified prior-allegation and enforcement-action exceptions1.

Can the owner amend claims during supplemental examination?

No, section 1.620(f) prohibits amendments during supplemental examination7.

06

How it connects

Often confused withInter partes review
Next step

Go from the term to the task

Read how the method works, run it on your own product or idea, then try a free tool.

  • 01 / How-toPatentability search: a practical guideCheck whether an invention is new before you spend on a filing.GuideRead
  • 02 / AI agentNovelty Search AI AgentAn AI agent that searches prior art for your invention and compares each reference with it feature by feature.Patsnap EurekaRun it
  • 03 / Free toolPatent draft style studioRewrite a technical description in claim language.AI resultTry tool

More next stepsHow to run a freedom-to-operate analysisAI prior art search

PublishedPatsnap Team
Updated 17 November 2026
Sources
  1. 35 U.S.C. 257: Supplemental examinations to consider, reconsider, or correct information. U.S. Congress · statute · 2011. Accessed 17 November 2026.
  2. 37 CFR 1.601: Filing of papers in supplemental examination. USPTO · regulation · eCFR text as of 2026-11-13. Accessed 17 November 2026.
  3. 37 CFR 1.625: Conclusion of supplemental examination; publication of supplemental examination certificate; procedure after conclusion. USPTO · regulation · eCFR text as of 2026-11-13. Accessed 17 November 2026.
  4. MPEP 2801: Introduction. USPTO · examination manual · section revised 2024. Accessed 17 November 2026.
  5. 37 CFR 1.605: Items of information. USPTO · regulation · eCFR text as of 2026-11-13. Accessed 17 November 2026.
  6. MPEP 2823: Differences Between Ex Parte Reexamination Under 35 U.S.C. 257 and Under 35 U.S.C. 302. USPTO · examination manual · section revised 2013. Accessed 17 November 2026.
  7. 37 CFR 1.620: Conduct of supplemental examination proceeding. USPTO · regulation · eCFR text as of 2026-11-13. Accessed 17 November 2026.
Disclaimer

General information only. This page explains a term and is provided for general information and reference only. It is not legal advice and must not be relied upon as such. It does not create an attorney-client relationship.

Sources and accuracy. Statements on this page are intended to be either general background or linked to a source listed under Sources. The explanations summarize and simplify those sources and leave out detail. Where this page differs from a cited source or from the current official text of a law or standard, rely on that source or text.

Rules vary and change. The law, standards and practice described here differ between jurisdictions and change through legislation, court decisions and revisions to official guidance and standards. This page was last checked against its sources on 17 November 2026 and may not reflect later changes. Check the current rules and official guidance in each jurisdiction that applies to you.

No FTO or validity opinion. Nothing on this page constitutes a freedom-to-operate, novelty, validity or infringement opinion. Any decision touching a live patent dispute should be verified independently and reviewed with qualified patent counsel.

Third-party names and marks. Party, attorney, judge and company names appear for identification only. Company names may be trademarks of their owners; their appearance does not, by itself, imply affiliation with or endorsement by Patsnap.

Corrections. If you believe a statement on this page is inaccurate or out of date, use “Share feedback” at the bottom of this page and tell us which statement and why.

Novelty Search AI AgentRun Novelty Search in Patsnap EurekaStart →

Help us improve

Something wrong, out of date, or missing on this page? Tell us and it goes straight to the team that maintains it.